Graham

(IN BRIEF) PATRIZIA has agreed to acquire Statkraft Varme, the district heating business of Statkraft AS, in a deal worth up to EUR 312 million. Statkraft Varme operates 13 plants in Norway and Sweden, supplying low-carbon heating to households, businesses, … Read the full press release →

(IN BRIEF) Alstom is celebrating the 150th anniversary of its Glasgow Traincare Centre, known as Polmadie Depot, with a public open day on 12 October—the first in 25 years. The event will feature historic and modern rolling stock displays, including … Read the full press release →

(IN BRIEF) The European Investment Bank (EIB) Group has appointed Aimilia Pistrika as Head of its Nicosia Office, effective September 1. She succeeds Antonis Papageorgiou, who had served on an interim basis since the office’s inauguration in November by President … Read the full press release →

(IN BRIEF) The European Investment Bank has signed a €250 million financing framework with Athens Water Supply and Sewerage Company (EYDAP) to support a €514 million investment plan modernising water and wastewater services for more than four million Attica residents. … Read the full press release →

(IN BRIEF) The European Investment Bank has disbursed the second €100 million tranche of a €200 million loan package to co-finance Cyprus’s extensive road improvement programme, with completion targeted for 2029. The funding—covering 50 percent of project costs—will support motorway, … Read the full press release →

(IN BRIEF) Bayer has filed for EU approval of icafolin‑methyl, its first new herbicide mode of action in over 30 years, after earlier submissions in Brazil, the U.S., and Canada. With peak sales estimated at €750 million, icafolin‑methyl is slated for … Read the full press release →

(IN BRIEF) Researchers at The Institute of Cancer Research and Queen Mary University have created EIRAs, a computational assay that predicts how bowel cancer cells evolve resistance to chemotherapy. By monitoring cell populations and applying evolutionary models, the tool differentiates … Read the full press release →

(IN BRIEF) The EIB and Greece’s CDLF have signed a €500 million loan under the Antonis Tritsis urban investment programme, bringing the EIB’s total commitment to €1 billion. The funds will support hundreds of local authority projects—ranging from water and … Read the full press release →

(IN BRIEF) The University of Southampton’s new E-beam lithography facility, which is the second of its kind globally, will significantly advance semiconductor technology in the UK. The facility, which provides unmatched accuracy in designing the components of future technologies, supports … Read the full press release →

(IN BRIEF) The European Investment Bank is teaming up with Growthfund to carry out Climate Risk and Vulnerability Assessments for the ports of Volos, Alexandroupoli, and Patras in Greece. The initiative will identify physical climate risks, propose adaptation measures, and … Read the full press release →

(IN BRIEF) Researchers at the University of Glasgow have demonstrated that users in passive virtual reality environments can experience radically altered perceptions of motion—including exaggerated or reversed movement—without experiencing discomfort or motion sickness. The study, to be presented at CHI … Read the full press release →

(IN BRIEF) In 2024, the European Investment Bank (EIB) Group provided €2.2 billion in financing to Greece, focusing on boosting energy resilience, supporting business growth, and enhancing disaster preparedness. Key projects included solar parks, grid upgrades, and disaster management infrastructure, … Read the full press release →

(IN BRIEF) The European Investment Bank (EIB) will provide advisory support to five Greek regions to facilitate their transition from lignite-based energy production to sustainable, renewable energy sources. Through a €2.75 million technical assistance fund, the EIB aims to promote … Read the full press release →

(IN BRIEF) Novartis has announced promising 96-week results from the Phase III ASC4FIRST trial, showcasing Scemblix® (asciminib) as a superior treatment for newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase (Ph+ CML-CP). Scemblix achieved significantly higher major … Read the full press release →